Treatment plan comparison between helical tomotherapy and MLC-based IMRT using radiobiological measures

Physics in Medicine and Biology

Volumn 52, Issue 13, 2007, Pages 3817-3836

  Mavroidis, Panayiotis ^a,b   Ferreira, Brigida Costa ^a,c   Shi, Chengyu ^d,e   Lind, Bengt K ^a   Papanikolaou, Nikos ^d,e  

^a STOCKHOLM UNIVERSITY   (Sweden)

^b UNIVERSITY HOSPITAL OF LARISSA   (Greece)

^c UNIVERSITY OF AVEIRO   (Portugal)

^d Mays Cancer Center at UT Health San Antonio   (United States)

^e University of Texas Health Science Center at San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL ORGANS; IMPLANTS (SURGICAL); MEDICAL APPLICATIONS; OPTICAL COLLIMATORS; PROBABILITY; TISSUE; TUMORS;

DOSE-VOLUME HISTOGRAMS (DVH); HELICAL TOMOTHERAPY (HT); INTENSITY-MODULATED RADIOTHERAPY (IMRT); PLAN EVALUATION; TREATMENT PLANNING SYSTEMS (TPS);

RADIOTHERAPY;

ADULT; ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; CASE REPORT; COLLIMATOR; COMPUTER PROGRAM; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; DOSIMETRY; HEAD AND NECK CANCER; HELICAL TOMOTHERAPY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; LUNG CANCER; MALE; OUTCOME ASSESSMENT; PRESCRIPTION; PRIORITY JOURNAL; PROBABILITY; PROSTATE CANCER; RADIATION DOSE; RADIATION RESPONSE; RADIOBIOLOGY; RADIOTHERAPY; TISSUE REACTION; TREATMENT PLANNING;

COMPUTER SIMULATION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS; PARTICLE ACCELERATORS; PROSTATIC NEOPLASMS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; SOFTWARE; TOMOGRAPHY, SPIRAL COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34250339319     PISSN: 00319155     EISSN: 13616560     Source Type: Journal    
DOI: 10.1088/0031-9155/52/13/011     Document Type: Article

References (42)

1. Aaltonen P, Brahme A, Lax I, Levernes S, Näslund I, Reitan J B and Turesson I 1997 Specification of dose delivery in radiation therapy. Recommendations by the Nordic Association of Clinical Physics (NACP) Acta Oncol. 36 (Suppl. 10) 1-32
2. Ågren A K 1995 Quantification of the response of heterogeneous tumors and organized normal tissues to fractionated radiotherapy Ph.D. Thesis University of Stockholm, Stockholm, Sweden
3. Ågren-Cronqvist A K, Brahme A and Turesson I 1990 Optimization of uncomplicated control for head and neck tumors Int. J. Radiat. Oncol. Biol. Phys. 19 1077-85
4. Bauman G, Yartsev S, Coad T, Fisher B and Kron T 2005 Helical TomoTherapy for craniospinal radiation Br. J. Radiol. 78 548-52
5. Boersma L J, Damen E M and De Boer R W 1995 Estimation of overall pulmonary function after irradiation using dose-effect relations for local functional injury Radiother. Oncol. 36 15-23
6. Brahme A 1984 Dosimetric precision requirements in radiation therapy Acta Radiol. Oncol. 23 379-91
7. Brahme A 1994 Which parameters of the dose distribution are best related to the radiation response of tumours and normal tissues? Proceedings of the Interregional Seminars for Europe, the Middle East and Africa Organized by the IAEA (Leuven) pp 37-58
8. Brahme A 1997 The need for accurate target and dose specifications in conventional and conformal radiation therapy-an introduction Acta Oncol. 36 789-92
9. Brahme A 2000 Development of radiation therapy optimization Acta Oncol. 39 579-95
10. Buffa F M et al 2001 Incorporating biologic measurements (SF2, CFE) into a tumor control probability model increases their prognostic significance: a study in cervical carcinoma treated with radiation therapy Int. J. Radiat. Oncol. Biol. Phys. 50 1113-22
11. Burman C et al 1991 Fitting of normal tissue tolerance data to an analytical function Int. J. Radiat. Biol. Phys. 21 123-35
12. Deasy J O 1997 Inter-patient and intra-tumor radiosensitivity heterogeneity Volume and Kinetics in Tumor Control and Normal Tissue Complications (Madison, WI: Medical Physics Publishing) pp 363-81
13. Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider J E, Shank B, Solin L J and Wesson A M 1991 Tolerance of normal tissue to therapeutic irradiation Int. J. Radiat. Oncol. Biol. Phys. 21 109-22
14. Eriksson F, Gagliardi G, Liendberg A, Lax I, Lee C, Levitt S, Lind B and Rutqvist L-E 2000 Long-term cardiac mortality following radiation therapy for Hodgkin's disease: analysis with the relative seriality model Radiother. Oncol. 55 153-62
15. Fenwick J D and Nahum A E 2001 Series model volume effects in a population of non-identical patients: how low is low? Phys. Med. Biol. 46 1815-34
16. Ferreira B C, Svensson R, Löf J and Brahme A 2003 The clinical value of non-coplanar photon beams in biologically optimized intensity modulated dose delivery on deep seated tumors Acta Oncol. 42 852-64
17. Gagliardi G et al 2000 Radiation pneumonitis after breast cancer irradiation: analysis of the complication probability using the relative seriality model Int. J. Radiat. Oncol. Biol. Phys. 46 373-81
18. ICRU Report 62 1999 Prescribing, recording and reporting photon beam therapy (supplement to ICRU report 50) International Commission on Radiation Units and Measurements 1-52
19. Jackson A, Ten Haken R K, Robertson J M, Kessler M L, Kutcher G J and Lawrence T S 1995 Analysis of clinical complication data for radiation hepatitis using a parallel architecture model Int. J. Radiat. Oncol. Biol. Phys. 31 883-91
20. Kutcher G J, Burman C, Brewster L, Goitein M and Mohan R 1991 Histogram reduction method for calculating complication probabilities for 3-dimensional treatment planning evaluations Int. J. Radiat. Oncol. Biol. Phys. 21 137-46
21. Kwa S et al 1998 Evaluation of two dose-volume histogram reduction models for the prediction of radiation pneumonitis Radiother. Oncol. 48 61-9
22. Källman P, Ågren A-K and Brahme A 1992a Tumor and normal tissue responses to fractionated non uniform dose delivery Int. J. Radiat. Biol. 62 249-62
23. Källman P, Lind B K and Brahme A 1992b An algorithm for maximizing the probability of complication free tumor control in radiation therapy Phys. Med. Biol. 37 871-90
24. Kölbl O, Richter S and Flentje M 2000 Influence of treatment technique on dose-volume histogram and normal tissue complication probability for small bowel and bladder Strahlenther. Onkol. 176 105-11
25. Lind B K 1991 Radiation therapy planning and optimization studied as inverse problems PhD Thesis University of Stockholm, Sweden
26. Lind B K, Mavroidis P, Hyodynmaa S and Kappas C 1999 Optimization of the dose level for a given treatment plan to maximize the complication free tumor cure Acta Oncol. 38 787-98
27. Löf J, Lind B K and Brahme A 1995 Optimal radiation beam profiles considering the stochastic process of patient positioning in fractionated radiation therapy Inverse Problems 11 1189-209
28. Mackie T R, Balog J, Ruchala K J, Shepard D, Aldridge J S, Fitchard E E, Reckwerdt P, Olivera G H, McNutt T and Metha M 1999 Tomotherapy Sem. Radiat. Oncol. 9 108-17
29. Mavroidis P, Laurell G, Kraepelien T, Fernberg J O, Lind B K and Brahme A 2003 Determination and clinical verification of dose-response parameters for esophageal stricture from head and neck radiotherapy Acta Oncol. 42 865-81
30. Mavroidis P, Lind B K and Brahme A 2001 Biologically effective uniform dose for specification, report and comparison of dose response relations and treatment plans Phys. Med. Biol. 46 2607-30
31. Mavroidis P et al 2000 Comparison of conformal radiation therapy techniques within the dynamic radiotherapy project 'Dynarad' Phys. Med. Biol. 45 2459-81
32. Mavroidis P et al 2005 Dose-response relations for anal sphincter regarding faecal leakage and blood or phlegm in stools after radiotherapy for prostate cancer Strahlenter. Onkol. 181 293-306
33. Nahum A E, Movsas B, Horwitz E M, Stobbe C C and Chapman J D 2003 Incorporating clinical measurements of hypoxia into tumor local control modeling of prostate cancer: implications for the alpha/beta ratio Int. J. Radiat. Oncol. Biol. Phys. 57 391-401
34. Niemierko A 1997 Reporting and analysing dose distributions: A concept of equivalent uniform dose Med. Phys. 24 103-10
35. Papanikolaou N and Shi C 2006 A useful tool for trial comparison and developing composite plan between Tomotherapy and Pinnacle Med. Phys. 33 2065
36. Papanikolaou N, Yan Y, Penagaricano J and Ratanatharathorn V 2002 The impact of daily patient setup error and tissue inhomogeneity on PTV coverage and OAR avoidance using IMRT Med. Phys. 29 1286
37. Pezner R D, Liu A, Han C, Chen Y-J, Schultheiss T E and Wong J Y C 2006 Dosimetric comparison of helical tomotherapy treatment and step-and-shoot intensity-modulated radiotherapy of retroperitoneal sarcoma Radiother. Oncol. 81 81-7
38. Roesink J M, Moerland M A, Battermann J J, Hordijk G J and Terhaard C H J 2001 Quantitative dose-volume response analysis of changes in parotid gland function after radiotherapy in the head-and-neck region Int. J. Radiat. Oncol. Biol. Phys. 51 938-46
39. Scrimger R A, Tome W A, Olivera G H, Reckwerdt P J, Mehta M P and Fowler J F 2003 Reduction in radiation dose to lung and other normal tissues using helical tomotherapy to treat lung cancer, in comparison to conventional field arrangements Am. J. Clin. Oncol. 26 70-78
40. Tsougos I, Nilsson P, Theodorou K, Kjellén E, Ewers S-B, Jarlman O, Lind B K, Kappas C and Mavroidis P 2006 NTCP modelling and pulmonary function tests evaluation for the prediction of radiation induced pneumonitis in non-small-cell lung cancer radiotherapy Phys. Med. Biol. 52 1055-73
41. Webb S 2000 Intensity-Modulated Radiation Therapy (Bristol: Institute of Physics Publishing)
42. Willner J, Baier K, Caragiani E, Tschammler A and Flentje M 2002 Dose, volume, and tumor control predictions in primary radiotherapy of non-small-cell lung cancer Int. J. Radiat. Oncol. Biol. Phys. 52 382-9